Opioid Withdrawal vs. Alcohol Withdrawal and Other Comparisons

Key Takeaways

• Opioid withdrawal is intensely uncomfortable but rarely life-threatening; alcohol and benzodiazepine withdrawal can cause fatal seizures and require urgent medical management.
• Opioid withdrawal symptoms overlap significantly with influenza, but clinical assessment tools like the COWS scale help clinicians distinguish between them.
• Serotonin syndrome can mimic some opioid withdrawal features but involves distinct symptoms like clonus, hyperthermia, and hyperreflexia that require different treatment.
• Opioid withdrawal and opioid overdose present with opposite clinical pictures — withdrawal involves dilated pupils and agitation, while overdose involves pinpoint pupils and respiratory depression.
• Treatment approaches differ fundamentally: opioid withdrawal benefits from buprenorphine (Suboxone/Sublocade) or clonidine, while alcohol and benzodiazepine withdrawal typically require benzodiazepines or barbiturates.

When someone experiences symptoms that could be withdrawal, understanding which substance is involved — or whether a non-withdrawal condition is actually responsible — is critical for appropriate treatment. Opioid withdrawal shares surface-level similarities with several other conditions, including alcohol withdrawal, benzodiazepine withdrawal, influenza, serotonin syndrome, and even opioid overdose itself. Misidentifying the cause can lead to delayed or inappropriate treatment.

This page compares opioid withdrawal to these conditions, focusing on the clinical differences that matter most for accurate diagnosis and safe management.

How Opioid Withdrawal Differs from Other Conditions

Why Comparisons Matter for Accurate Diagnosis

Polysubstance use is common among individuals with substance use disorders. According to SAMHSA, a significant proportion of people who use opioids also use alcohol, benzodiazepines, or other substances. When someone presents in withdrawal, identifying which substance (or substances) is driving the symptoms determines:

• Immediate safety risk — alcohol and benzodiazepine withdrawal can be fatal; opioid withdrawal generally is not
• Medication choices — the wrong medication can be ineffective or harmful
• Monitoring intensity — seizure risk from alcohol or benzodiazepine withdrawal demands a different level of clinical vigilance
• Treatment planning — co-occurring withdrawal syndromes require coordinated management

Emergency departments, detox facilities, and families all benefit from understanding these distinctions. In New Jersey, where polysubstance use involving opioids and benzodiazepines is well-documented, clinicians routinely assess for multiple simultaneous withdrawal syndromes.

Opioid Withdrawal vs. Alcohol Withdrawal

Symptom Overlap and Key Differences

Opioid and alcohol withdrawal share several symptoms — anxiety, sweating, elevated heart rate, nausea, insomnia, and general malaise. This overlap is why clinical assessment, rather than symptom observation alone, is necessary for accurate diagnosis.

Feature	Opioid Withdrawal	Alcohol Withdrawal
Onset	6-24 hours after last use	6-24 hours after last drink
Peak symptoms	Days 2-3 (short-acting)	Days 2-3
Pupil changes	Dilated (mydriasis)	Normal or slightly dilated
GI symptoms	Severe (vomiting, diarrhea)	Moderate (nausea, vomiting)
Seizure risk	Very low	Significant — can be fatal
Delirium tremens	Does not occur	Occurs in 3-5% of cases; carries up to 37% mortality if untreated
Hallucinations	Rare	Common in severe cases
Mortality risk	Low (primarily from dehydration)	Significant without medical treatment
Primary treatment	Buprenorphine or clonidine	Benzodiazepines

Lethality Risk: A Critical Distinction

The most important clinical difference between opioid and alcohol withdrawal is lethality. Alcohol withdrawal syndrome can progress to delirium tremens (DTs) — a medical emergency characterized by severe confusion, hallucinations, autonomic instability, and seizures. Without treatment, DTs can be fatal.

Opioid withdrawal, while subjectively devastating, does not produce seizures or DTs. The primary medical risks are dehydration from GI fluid losses and cardiac complications in individuals with pre-existing heart conditions. This distinction does not minimize the suffering of opioid withdrawal, but it does change the clinical urgency profile.

For individuals withdrawing from both alcohol and opioids simultaneously — a situation that requires immediate medical attention — the alcohol withdrawal takes clinical priority due to its seizure and mortality risk.

Opioid Withdrawal vs. Benzodiazepine Withdrawal

Seizure Risk and Taper Protocols

Benzodiazepine withdrawal — from medications like alprazolam (Xanax), diazepam (Valium), clonazepam (Klonopin), and lorazepam (Ativan) — shares opioid withdrawal’s intense anxiety and insomnia but differs in one critical respect: benzodiazepine withdrawal can cause seizures and death.

Feature	Opioid Withdrawal	Benzodiazepine Withdrawal
Seizure risk	Minimal	Significant, especially with abrupt cessation
Safe to stop abruptly	Yes (medically supervised)	No — taper required
Duration	7-14 days acute	Weeks to months
Primary treatment	Buprenorphine, clonidine	Gradual taper with long-acting benzodiazepine
Rebound anxiety	Moderate	Severe and prolonged
Perceptual disturbances	Rare	Common (visual, auditory)

Both benzodiazepines and alcohol act on the GABA system, which is why their withdrawal syndromes share the seizure risk that opioid withdrawal lacks. Opioid withdrawal involves noradrenergic rebound rather than GABA-mediated excitotoxicity.

Duration Differences

Benzodiazepine withdrawal can last significantly longer than opioid withdrawal. While acute opioid withdrawal typically resolves within 7 to 14 days, benzodiazepine withdrawal may take weeks or months, particularly with long-acting benzodiazepines. Protracted benzodiazepine withdrawal syndrome — with persistent anxiety, insomnia, and cognitive difficulties — can last a year or more in some cases.

This extended timeline makes benzodiazepine withdrawal particularly challenging for individuals who also have opioid use disorder. Concurrent withdrawal from both substances requires careful clinical management, ideally in an inpatient setting. For more on benzodiazepine-specific considerations, see our page on alcohol withdrawal, which discusses similar GABA-related withdrawal dynamics.

Opioid Withdrawal vs. the Flu

Shared Symptoms

People frequently describe opioid withdrawal as the worst flu they have ever experienced, and the comparison is apt on the surface. Both conditions share:

• Muscle and body aches
• Fatigue and malaise
• Rhinorrhea (runny nose)
• Sweating and chills
• Nausea and GI upset
• Low-grade fever

This resemblance is not coincidental. Both conditions involve activation of similar inflammatory and immune pathways, and both produce sympathetic nervous system activation. The overlap is significant enough that individuals early in withdrawal sometimes convince themselves — or are told by others — that they simply have the flu.

How Clinicians Tell Them Apart

Several clinical markers distinguish opioid withdrawal from influenza:

• Pupil dilation: Opioid withdrawal produces pronounced mydriasis; the flu does not significantly affect pupil size
• Piloerection (goosebumps): Prominent in opioid withdrawal, not characteristic of influenza
• Yawning: Excessive, repetitive yawning is an early hallmark of opioid withdrawal
• Drug use history: Known opioid use, track marks, or positive toxicology screening
• Timing relative to last opioid use: Symptom onset correlating with the expected withdrawal timeline
• Response to opioids: Withdrawal symptoms resolve rapidly with opioid administration; flu symptoms do not

The COWS (Clinical Opiate Withdrawal Scale) assessment provides a structured framework for evaluating these distinguishing features. In emergency departments, urine drug screening can also help establish whether recent opioid use makes withdrawal the more likely diagnosis.

Opioid Withdrawal vs. Serotonin Syndrome and Overdose

Recognizing Serotonin Syndrome

Serotonin syndrome is a potentially life-threatening condition caused by excess serotonergic activity, often from drug interactions. It can mimic opioid withdrawal in some presentations but involves distinct features:

Feature	Opioid Withdrawal	Serotonin Syndrome
Pupils	Dilated	Dilated
Sweating	Present	Present
Agitation	Present	Present
Clonus	Absent	Present (distinguishing feature)
Hyperreflexia	Absent	Present
Hyperthermia	Mild or absent	Can be severe (>40C/104F)
Muscle rigidity	Absent	Present, especially lower extremities
Diarrhea	Prominent	Can be present
Onset	Gradual (hours after cessation)	Rapid (within hours of causative drug)

Serotonin syndrome is particularly relevant in the addiction treatment context because certain opioids — notably tramadol and meperidine — have serotonergic properties, and patients on MAT may also take antidepressants. The combination of a serotonergic opioid with an SSRI, SNRI, or MAO inhibitor can trigger the syndrome.

The key clinical differentiator is neuromuscular findings: clonus (involuntary rhythmic muscle contractions), hyperreflexia, and muscle rigidity point to serotonin syndrome rather than opioid withdrawal.

Withdrawal vs. Overdose Presentation

Opioid withdrawal and opioid overdose are essentially opposite clinical presentations, but confusion can arise — particularly among family members witnessing distress.

Feature	Opioid Withdrawal	Opioid Overdose
Consciousness	Alert, agitated	Sedated, unresponsive
Pupils	Dilated	Constricted (pinpoint)
Respiratory rate	Normal or elevated	Dangerously low or absent
Heart rate	Elevated	May be low or normal
Skin	Flushed, sweating	Blue/gray (cyanotic)
Immediate danger	Low (primarily dehydration)	Life-threatening — respiratory arrest
Emergency response	Medical detox, symptom management	Naloxone (Narcan) administration, call 911

This distinction is critical. Opioid overdose is a medical emergency requiring immediate naloxone (Narcan) administration and emergency medical services. Withdrawal, while distressing, does not require the same emergency response.

In New Jersey, naloxone (Narcan) is available without a prescription at pharmacies under a statewide standing order. The state also distributes free naloxone kits through community organizations and harm reduction programs.

Understanding the difference between these presentations can be lifesaving for families of individuals with opioid use disorder.

---

This article is part of our complete guide to opioid addiction in New Jersey. For detailed information about opioid withdrawal specifically, see opioid withdrawal symptoms timeline and opioid withdrawal medications and treatment.

For information on alcohol withdrawal, see our page on alcohol withdrawal syndrome. For general detox resources, visit our guide to medical detox.